Professor Susmito Biswas
Consultant Paediatric Ophthalmologist and Ophthalmic SurgeonQualifications
BSc.(Hons), MB BS, FRCOphth
Specialist Interests
Paediatric ophthalmology including retinopathy of prematurity, paediatric corneal and anterior segment developmental disorders, external eye diseases in children, paediatric cataract and paediatric glaucoma, paediatric strabismus and amblyopia.
Biography
Professor Biswas graduated in Medicine and Surgery from St Bartholomew’s Hospital Medical School, London, in 1992. He completed his higher specialist training in ophthalmology at Manchester Royal Eye Hospital before further advancing his expertise with fellowship training in paediatric ophthalmology at Great Ormond Street Hospital and King’s College Hospital, London.
Since 2002, Professor Biswas has served as a consultant ophthalmologist at Manchester Royal Eye Hospital. Between 2012 and 2018, he held the position of Clinical Head of Division at the Manchester Royal Eye Hospital and served as the Clinical Lead for Paediatric Ophthalmology until 2025. He was awarded a Manchester Academic Health Sciences Honorary Chair at Manchester University in 2023 and currently holds the role of Vice President of the British Isles Paediatric Ophthalmology and Strabismus Association (BIPOSA).
Professor Biswas is recognised for his expertise in the care of infants and children with severe corneal diseases, being one of the leading paediatric corneal transplant surgeons in the UK. He also leads the Retinopathy of Prematurity Service in Greater Manchester and is the Ophthalmic Lead for Retinopathy of Prematurity in the North West Neonatal Operational Delivery Network ROP screening transformation programme. He leads the ophthalmology service for Cystinosis in Children in Manchester (one of three designated hubs for treatment of this rare disease in the UK). In addition to his clinical work, Professor Biswas has a strong presence in national and international ophthalmic communities. He was Chair of the Royal College of Ophthalmologists’ Paediatric Subcommittee from 2019 to 2024 and has been instrumental in the development of guidelines for retinopathy of prematurity screening and treatment. He has also contributed to the development of guidelines for ophthalmic findings in abusive head injury and paediatric Stevens-Johnson syndrome/Toxic Epidermal Necrolysis and international guidelines for Nephropathic Cystinosis.
He is recognised for his clinical excellence, research contributions, and leadership within the field, having delivered the prestigious Duke Elder Lecture of the Annual Congress the Ophthalmologists in 2023. He is actively involved in research, serving as the Principal Investigator for three industry-sponsored studies and one investigator-led multicentre randomized controlled trial at Manchester Royal Eye Hospital. Additionally, he has been a co-investigator in gene therapy trials. He has authored and co-authored over 80 peer reviewed publications.
Through his extensive training and leadership roles, Professor Biswas has mentored many paediatric ophthalmologists, many of whom now hold consultant positions in prominent hospitals in the UK, Ireland, and internationally.
